Featured Research

from universities, journals, and other organizations

"Exciting" Discovery Might Improve Cancer Treatment

Date:
March 30, 1999
Source:
University Of North Carolina At Chapel Hill
Summary:
University of North Carolina at Chapel Hill scientists have discovered they can shrink -- and in many cases eliminate - human tumors grown in laboratory animals by inhibiting a natural mechanism that prevents tumor cells from dying.

CHAPEL HILL - University of North Carolina at Chapel Hill scientists have discovered they can shrink -- and in many cases eliminate - human tumors grown in laboratory animals by inhibiting a natural mechanism that prevents tumor cells from dying.

Related Articles


Although not yet tried directly in humans, scientists believe their technique could one day significantly improve survival among patients with many kinds of cancer. They are planning the first human tests, which should begin later this year.

The mechanism they've studied for more than three years involves NF-kappa B, a protein that attaches to DNA inside the nucleus of cells and turns genes on and off like a switch. Doctors use chemotherapy or radiation to kill cancer cells, but the UNC-CH researchers reported two and a half years ago that NF-kappa B kicks in and soon enables many cultured tumor cells to escape death. After developing resistance to the therapy, the cancer cells continue reproducing and show no ill effects from the treatment.

In the latest experiments, the scientists used a novel cancer gene therapy strategy to block NF-kappa B in mice with a natural inhibitor protein known as I-kappa B. Human tumors growing in the mice then became susceptible to chemotherapy and in some cases disappeared altogether following treatment.

A report on the discovery appears in the April issue of Nature Medicine, a scientific journal. Authors - all affiliated with the UNC Lineberger Comprehensive Cancer Center - are Dr. Cun-Yu Wang, a former graduate student and now clinical instructor in endodontics; Dr. James C. Cusack, assistant professor of surgery; laboratory technician Rong Liu; and Dr. Albert S. Baldwin Jr., associate professor of biology.

"Our results are dramatic, and we believe they are going to be extraordinarily important for therapy of different kinds of cancer," said Baldwin, associate director of the Lineberger Center. "Although not everything that works in animals also works in humans, many times they do work. Because we think this is a mechanism that is important generally, and we now know how to counteract it, we are very optimistic."

In the past, he said, no one has understood why many tumors don't respond to chemotherapy and radiation. NF-kappa B appears to be a front-line defense protecting both healthy cells and cancer cells from chemical attack.

In the new experiments, researchers concentrated on human colorectal and fibrosarcoma tumors. They grew the tumors in mice and then treated them with a modified form of the inhibitor I-kappa B carried by a virus that could enter tumor cells. Treatment with a commonly used chemotherapy compound known as CPT-11 was "eminently more successful," Baldwin said, when coupled with I-kappa B than when used by itself.

Cusack, a surgical oncologist specializing in gene therapy, agreed that results so far were "very exciting." He and colleagues are now devising tumor models for other forms of cancer and expect to win U.S. Food and Drug Administration approval for a variety of clinical trials based on the new findings.

"This forms the basis for developing a novel treatment strategy that is being explored further in preclinical studies and should be available to patients within the year," Cusack said. "These findings provide new insight into why many cancer cells frequently don't die when exposed to chemotherapy. The approach demonstrates a successful means of how we might overcome cancer cells' defense mechanisms to make treatment more effective."

He called the work a good example of the potential benefits of basic research that seeks to explain fundamental biology without preconceived notions and immediate applications.

Support for the studies came from the National Cancer Institute, the American Cancer Society, the UNC Lineberger Comprehensive Cancer Center and the Leukemia Society of America.


Story Source:

The above story is based on materials provided by University Of North Carolina At Chapel Hill. Note: Materials may be edited for content and length.


Cite This Page:

University Of North Carolina At Chapel Hill. ""Exciting" Discovery Might Improve Cancer Treatment." ScienceDaily. ScienceDaily, 30 March 1999. <www.sciencedaily.com/releases/1999/03/990330071915.htm>.
University Of North Carolina At Chapel Hill. (1999, March 30). "Exciting" Discovery Might Improve Cancer Treatment. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/1999/03/990330071915.htm
University Of North Carolina At Chapel Hill. ""Exciting" Discovery Might Improve Cancer Treatment." ScienceDaily. www.sciencedaily.com/releases/1999/03/990330071915.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins